Medicare drug price negotiations move forward with all drugmakers participating, White House says By: MarketWatch October 03, 2023 at 08:00 AM EDT Novo Nordisk is latest drugmaker to challenge negotiation program in court. Read More >> Related Stocks: AbbVie Bristol-Myers Squibb Johnson & Johnson Merck & Co Novo Nordisk A/S ADR